dm+d

108622005

Articles

Safety in Lactation: Corticosteroids

9 November 2020There is very limited information on the use of corticosteroids during breastfeeding, although they are likely to be present in milk. Avoid prolonged high dose…

Safety in Lactation: Drugs used in nasal allergy

27 October 2020Drugs used for nasal allergy have limited systemic absorption in the mother, and pose negligible risk to a breastfed infant. There is no published evidence…

Safety in Lactation: Drugs for obstructive airways disease

25 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Bronchodilators Most bronchodilators are considered to…

Safety in lactation: Drugs for chronic bowel disorders

21 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Aminosalicylates for chronic bowel disorders Mesalazine…
Search Articles

New Medicines

Moderate to severe asthma

Information

New formulation
AstraZeneca
AstraZeneca

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Inhaled corticosteroid and short acting bronchodilator, used when required. Each dose of PT027 delivers 160μg budesonide (ICS) and 180μg salbutamol.
5.4 million people in the UK receive treatment for asthma: 1 in 11 children and 1 in 12 adults. It is the most common chronic medical condition in children [1].
Moderate to severe asthma
Inhalation